Related Experiment Video
Updated: May 28, 2026

A Novel in vivo Gene Transfer Technique and in vitro Cell Based Assays for the Study of Bone Loss in Musculoskeletal Disorders
Published on: June 8, 2014
Kindlin-2 functional restoration through methylmalonic acid clearance by coenzyme A counteracts osteoporosis
Xuling Li1, Guixing Ma1, Fen Wang1
1Department of Biochemistry, SUSTech Homeostatic Medicine Institute, School of Medicine, Guangdong Provincial Key Laboratory of Cell Microenvironment and Disease Research, Shenzhen Key Laboratory of Cell Microenvironment, Key University Laboratory of Metabolism and Health of Guangdong, Southern University of Science and Technology, Shenzhen 518055, China.
Abstract:
Old blood can induce senescence in young mice, yet the underlying mechanisms remain unclear. Here, we demonstrate that non-protein components (NPs) of aged human serum (ONPs) induce skeletal aging in young mice, with methylmalonic acid (MMA) identified as a key driver capable of independently recapitulating the skeletal aging phenotypes observed in ONP-treated mice. Photoaffinity labeling confirms Kindlin-2 as a direct intracellular MMA receptor. MMA binds directly to Kindlin-2 via a positively charged motif in its UBL domain, promoting Kindlin-2 ubiquitination and degradation, which accelerates skeletal aging. Notably, the endogenous MMA scavenger coenzyme A (CoA), a clinically approved molecule, effectively reverses MMA- and ONP-induced skeletal aging. Furthermore, CoA treatment effectively protects against skeletal aging and bone mass loss in aged or estrogen-deficient mouse models. Our study establishes MMA as a central aging factor and Kindlin-2 as its intracellular receptor, offering a potential therapeutic strategy for age-related diseases such as osteoporosis.
Insights
Old blood components accelerate skeletal aging by increasing methylmalonic acid (MMA). This molecule targets Kindlin-2, but coenzyme A (CoA) can reverse these effects, offering a potential therapy for osteoporosis.
Area of Science:
- Biogerontology
- Skeletal Biology
- Molecular Mechanisms of Aging
Background:
- Old blood is known to induce senescence, but the specific molecular drivers of age-related skeletal decline are not fully understood.
- Non-protein components of aged serum contribute to skeletal aging phenotypes in younger organisms.
Purpose of the Study:
- To identify the key molecular components in aged serum responsible for inducing skeletal aging.
- To elucidate the mechanism by which these components affect bone health.
- To explore potential therapeutic interventions for age-related bone loss.
Main Methods:
- Administration of aged human serum (non-protein components) to young mice.
- Identification of methylmalonic acid (MMA) as a key aging factor using biochemical assays.
- Photoaffinity labeling to identify the intracellular receptor for MMA.
- Analysis of MMA binding to Kindlin-2 and its downstream effects (ubiquitination, degradation).
- Treatment with coenzyme A (CoA) to assess its therapeutic potential in mouse models of aging and estrogen deficiency.
Main Results:
- Non-protein components of aged human serum (ONP) induced skeletal aging in young mice.
- Methylmalonic acid (MMA) was identified as a key driver of these aging phenotypes.
- Kindlin-2 was confirmed as a direct intracellular MMA receptor, with MMA binding promoting its degradation.
- Coenzyme A (CoA), an endogenous MMA scavenger, reversed MMA- and ONP-induced skeletal aging.
- CoA treatment also protected against age-related bone loss and bone mass reduction in aged and estrogen-deficient mice.
Conclusions:
- Methylmalonic acid (MMA) is a critical factor in age-related skeletal decline, acting via the intracellular receptor Kindlin-2.
- Targeting MMA or enhancing its clearance, for example, with coenzyme A (CoA), represents a promising therapeutic strategy for osteoporosis and other age-related bone diseases.
Related Concept Videos
Role of Vitamins in Maintaining Bone Health
Vitamin A
Vitamin A is involved in the process of bone remodeling. Retinoic acid, the active metabolite of Vitamin A, has nuclear receptors in osteoblasts and osteoclasts, which are involved in bone remodeling.
Vitamin B12
Vitamin B12 acts as a cofactor during the formation of osteoblast-related proteins, such as osteocalcin. Vitamin B12 plays a role...
Bone Disorders
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Bone Remodeling
Phase II Reactions: Methylation Reactions
The mechanism of methylation unfolds in two stages. The first stage sees a methyltransferase enzyme facilitating the transfer of a methyl group from S-adenosylmethionine (SAM) to the substrate, forming S-adenosylhomocysteine (SAH). The second stage involves further metabolism of SAH into homocysteine, which can be recycled...
Osteoclasts in Bone Remodeling
Essential Minerals for Bone Health
Calcium and Phosphorus
Calcium is a critical component of bones, especially in the form of calcium phosphate and calcium carbonate. Since the body cannot make calcium, it must be obtained from the diet. However, calcium cannot be absorbed from the small intestine without...